News: Biotron's Hep C drug candidate phase 2a tri, page-5

  1. 765 Posts.
    re: News: Biotron's Hep C drug candidate phas...
    There are a few things to get exited about here...

    >Healthy Volume today.

    >Michelle Millers interveiw alluded to the fact that not only is bit225 compatable with interferon/ribavirin but probably the newer generation of treatments,this means 2 or possibly 3 avenues with seperate pharma heavyweights.

    >They seem confident that they will get the same level of results with HIV.

    GL Holders
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.2¢
Change
0.000(0.00%)
Mkt cap ! $2.654M
Open High Low Value Volume
0.2¢ 0.2¢ 0.2¢ $1.606K 803.1K

Buyers (Bids)

No. Vol. Price($)
58 39950557 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 17911809 22
View Market Depth
Last trade - 14.19pm 01/07/2025 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.